Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platelet Glycoprotein IIb/IIIa Blockers During Percutaneous Coronary Intervention and as the Initial Medical Treatment of non-ST Segment Elevation Acute Coronary Syndromes: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/Platelet_glycoprotein_IIb_IIIa_blockers_during_percutaneous_coronary_intervention_and_as_the_initial_medical_treatment_of_non_ST_segment_elevation_acute_coronary_syndromes:_Cochrane_systematic_review.
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/Platelet_glycoprotein_IIb_IIIa_blockers_during_percutaneous_coronary_intervention_and_as_the_initial_medical_treatment_of_non_ST_segment_elevation_acute_coronary_syndromes:_Cochrane_systematic_review. Accessed February 14, 2025.
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/Platelet_glycoprotein_IIb_IIIa_blockers_during_percutaneous_coronary_intervention_and_as_the_initial_medical_treatment_of_non_ST_segment_elevation_acute_coronary_syndromes:_Cochrane_systematic_review
Platelet Glycoprotein IIb/IIIa Blockers During Percutaneous Coronary Intervention and as the Initial Medical Treatment of non-ST Segment Elevation Acute Coronary Syndromes: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/Platelet_glycoprotein_IIb_IIIa_blockers_during_percutaneous_coronary_intervention_and_as_the_initial_medical_treatment_of_non_ST_segment_elevation_acute_coronary_syndromes:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes: Cochrane systematic review
ID - 439019
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439019/all/Platelet_glycoprotein_IIb_IIIa_blockers_during_percutaneous_coronary_intervention_and_as_the_initial_medical_treatment_of_non_ST_segment_elevation_acute_coronary_syndromes:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -